Why this grouping
MONDO alignment & provenance
IUIS Table 8 aligns with MONDO complement deficiency (MONDO:0003832). broadMatch rather than exactMatch because MONDO's class is not restricted to germline monogenic inborn errors, whereas IUIS Table 8 is; the MONDO term is therefore wider than this grouping.
MONDO consistency: consistent The listed member is an is-a descendant of MONDO:0003832, verified 2026-08-20 with `runoak -i sqlite:obo:mondo descendants -p i MONDO:0003832` (immunodeficiency due to a late component of complement deficiency, MONDO:0015700).
Membership criteria
- HAS CLASSIFICATION
Assigned to IUIS Table 8 (complement deficiencies) via classifications.iuis_category on the member Disease entry. Stated in the keyed `<slot>:<value>` form so the audit reads the structured classifications block.
Coverage and gaps
No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Assigned to IUIS Table 8 (complement deficiencies) via classifications.iuis_category on the member Disease entry. Stated in the keyed `<slot>:<value>` form so the audit reads the structured classifications block. |
|---|---|---|---|---|---|---|---|---|
| listed with MONDO ID |
Late Complement Component Deficiency
DISEASE
Differentiating mechanismBiallelic loss of any terminal component (C5, C6, C7, C8, C9) prevents assembly of the membrane attack complex C5b-9 and so abolishes direct serum bactericidal activity. Because Neisseria are killed principally by MAC lysis rather than by opsonophagocytosis, the deficiency produces an almost pathognomonic susceptibility to recurrent invasive meningococcal and disseminated gonococcal disease with otherwise unremarkable immunity — the terminal-pathway arm of Table 8.
C5 hgnc:1331
|
immunodeficiency due to a late component of complement deficiency
MONDO:0015700
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
Open questions & knowledge gaps
Curated open questions about this grouping's boundary, coverage, or evidence. These record what is not settled, so they are claims about the curation rather than about the biology unless the rationale says otherwise.
Proposed experiments
- Curate early-classical and regulatory complement deficiency entries — Curate at least one early classical-pathway deficiency (C1q, C1r/C1s, C2 or C4, presenting as SLE-like immune-complex disease) and one regulatory defect, assign each `classifications.iuis_category: complement deficiency`, and add them here. With three cascade positions represented, the pathway-position-predicts-phenotype claim becomes auditable as a structured contrast between members rather than an assertion in the grouping rationale.
Source
View YAML on GitHubRaw YAML
name: Complement Deficiency IEIs
display_name: Complement Deficiency IEIs (IUIS Table 8)
creation_date: "2026-08-20T00:00:00Z"
description: >-
IUIS Table 8 — complement deficiencies. These inborn errors of immunity
disable a component or regulator of the complement cascade, an innate humoral
effector system that operates without cells. The infection phenotype is
strikingly pathway-specific: terminal-component defects impair membrane
attack complex assembly and admit Neisseria almost exclusively, while early
classical-pathway defects impair immune-complex clearance and present as
lupus-like autoimmunity.
grouping_basis:
- SHARED_MECHANISM
- SHARED_PHENOTYPE
grouping_rationale: >-
Grouped on the IUIS Table 8 lesion in the complement system. Complement is
kept as its own table, and its own grouping, rather than being folded into
innate immunity (Table 6): it is a soluble cascade rather than a cellular
program, its deficiencies are inherited as clean autosomal recessive
enzymopathies of individual components, and the position of the defect within
the cascade — early classical, alternative, lectin, terminal, or regulatory —
predicts the clinical phenotype directly. Members are kept as separate Disease
entries because that cascade position differs.
mappings:
mondo_mappings:
- term:
id: MONDO:0003832
label: complement deficiency
mapping_predicate: skos:broadMatch
mapping_source: MONDO
mapping_justification: >-
IUIS Table 8 aligns with MONDO complement deficiency (MONDO:0003832).
broadMatch rather than exactMatch because MONDO's class is not restricted
to germline monogenic inborn errors, whereas IUIS Table 8 is; the MONDO
term is therefore wider than this grouping.
consistency:
- reference: MONDO
consistent: CONSISTENT
notes: >-
The listed member is an is-a descendant of MONDO:0003832, verified
2026-08-20 with `runoak -i sqlite:obo:mondo descendants -p i
MONDO:0003832` (immunodeficiency due to a late component of complement
deficiency, MONDO:0015700).
membership_criteria:
- description: >-
A disorder belongs to IUIS Table 8 if it is an inborn error of immunity
caused by deficiency of a complement component or complement regulatory
protein.
criteria_semantics: NECESSARY
logic:
criterion_predicate: HAS_CLASSIFICATION
classification: "iuis_category:complement deficiency"
description: >-
Assigned to IUIS Table 8 (complement deficiencies) via
classifications.iuis_category on the member Disease entry. Stated in the
keyed `<slot>:<value>` form so the audit reads the structured
classifications block.
members:
- member: Late Complement Component Deficiency
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic loss of any terminal component (C5, C6, C7, C8, C9) prevents
assembly of the membrane attack complex C5b-9 and so abolishes direct
serum bactericidal activity. Because Neisseria are killed principally by
MAC lysis rather than by opsonophagocytosis, the deficiency produces an
almost pathognomonic susceptibility to recurrent invasive meningococcal
and disseminated gonococcal disease with otherwise unremarkable immunity —
the terminal-pathway arm of Table 8.
gene:
preferred_term: C5
term:
id: hgnc:1331
label: C5
notes: >-
Created 2026-08-20 to give the IUIS Table 8 disorders a place in the Inborn
Errors of Immunity tree; the member already carried
`classifications.iuis_category: complement deficiency` but was unreachable
from the umbrella grouping. Single-member for now: the early classical-pathway
(C1q/C1r/C1s/C2/C4), alternative-pathway, lectin-pathway and regulatory
(C1-inhibitor, factor H/I, CD55/CD59) arms of Table 8 are not yet curated in
kb/disorders/ — see the `complement_table8_pathway_coverage` discussion.
discussions:
- discussion_id: complement_table8_pathway_coverage
kind: KNOWLEDGE_GAP
prompt: >-
Does a single terminal-pathway member support the phenotype claim this
grouping makes about complement deficiency as a class?
rationale: >-
The clinically important property of Table 8 is that the position of the
defect within the cascade predicts the phenotype — terminal defects give
neisserial infection, early classical defects give lupus-like autoimmunity
and immune-complex disease, regulatory defects give hereditary angioedema
or atypical haemolytic uraemic syndrome. With only the terminal arm curated,
the grouping states that contrast in prose but cannot demonstrate it across
members, and a SUFFICIENT criterion cannot be written because the criteria
would have to enumerate phenotypes the KB does not yet carry. This is a
coverage gap in kb/disorders/ rather than an open scientific question, but
it bounds what this grouping can currently audit.
proposed_experiments:
- experiment_id: curate_early_and_regulatory_complement_defects
name: Curate early-classical and regulatory complement deficiency entries
description: >-
Curate at least one early classical-pathway deficiency (C1q, C1r/C1s, C2
or C4, presenting as SLE-like immune-complex disease) and one regulatory
defect, assign each `classifications.iuis_category: complement
deficiency`, and add them here. With three cascade positions represented,
the pathway-position-predicts-phenotype claim becomes auditable as a
structured contrast between members rather than an assertion in the
grouping rationale.